Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Diltiazem, Atc C08db01 For The Period May 1, 2026 - April 30, 2028 (plus V. Option 1x12 Months) 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Pimecrolimus, Atc D11ah02 For The Period May 1, 2026 - April 30, 2028 (plus V. Option 1x12 Months) 2026-09-12
Germany Open House Drug Discount Agreements Safinamide, Atc N04bd03 2026-09-12
Germany Open House Drug Discount Agreements Clobetasol, Atc D07ad01 2026-09-12
Germany Open House Drug Discount Agreements Daridorexant, Atc N05cj03 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Abs. 8 Sgb V For The Active Ingredient Moxifloxacin For The Period 01.05.26 - 30.04.28 (plus Option For 1x12 Months). Moxifloxacin 2026-09-12
Germany Open House Drug Discount Agreements Atovaquone, Atc P01ax06 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement For The Active Ingredient Ciclopirox, Valid From May 1, 2026, To April 30, 2028, With An Optional Extension Of 12 Months. Ciclopirox 2026-09-12
Germany Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Dydrogesterone + Estrogen, Atc G03fb08 For The Period May 1, 2026 - April 30, 2028 (plus V. Option 1x12 Months) 2026-09-12
Germany Open House Drug Discount Agreements Nintedanib, Atc L01ex09 2026-09-12
Whats app